- Report
- March 2025
- 200 Pages
Global
From €4293EUR$4,490USD£3,593GBP
- Clinical Trials
- July 2024
- 80 Pages
Global
From €1912EUR$2,000USD£1,601GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1195EUR$1,250USD£1,000GBP
Schizoaffective disorder is a mental health disorder that combines features of both schizophrenia and a mood disorder, such as depression or bipolar disorder. Symptoms of schizoaffective disorder can include hallucinations, delusions, disorganized speech, and disorganized behavior. People with schizoaffective disorder may also experience changes in mood, such as depression or mania. Treatment for schizoaffective disorder typically includes a combination of medication and psychotherapy.
The schizoaffective disorder market is a growing segment of the mental health industry. Companies in this market are focused on developing treatments and therapies to help people with schizoaffective disorder manage their symptoms. These companies are also researching new treatments and therapies to improve the quality of life for those living with schizoaffective disorder.
Some companies in the schizoaffective disorder market include Otsuka Pharmaceuticals, Sunovion Pharmaceuticals, and Lundbeck. Other companies in the market include Allergan, Intra-Cellular Therapies, and Neurocrine Biosciences. Show Less Read more